Evolution of the Serbian pharmaceutical market alongside socioeconomic transition
- 16 January 2015
- journal article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 15 (3) , 521-530
- https://doi.org/10.1586/14737167.2015.1003044
Abstract
(2015). Evolution of the Serbian pharmaceutical market alongside socioeconomic transition. Expert Review of Pharmacoeconomics & Outcomes Research: Vol. 15, No. 3, pp. 521-530. doi: 10.1586/14737167.2015.1003044Keywords
This publication has 24 references indexed in Scilit:
- Cross-sectional survey on complementary and alternative medicine awareness among health care professionals and students using CHBQ questionnaire in a Balkan countryChinese Journal of Integrated Medicine, 2013
- Out‐of‐pocket payments for public healthcare services by selected exempted groups in Serbia during the period of post‐war healthcare reformsThe International Journal of Health Planning and Management, 2013
- Financial crisis, austerity, and health in EuropeThe Lancet, 2013
- Measuring the catastrophic and impoverishing effect of household health care spending in SerbiaSocial Science & Medicine, 2013
- European drug shortages: a call for action!International Journal of Pharmacy Practice, 2013
- Resource allocation strategies in Southeastern European health policyThe European Journal of Health Economics, 2012
- The Global Economy as Instituted Process: The Case of Central and Eastern EuropeAmerican Sociological Review, 2009
- The unfinished journey from Semashko to Bismarck: health reform in Central Asia from 1991 to 2006Central Asian Survey, 2006
- The Transition of Young People in a Transitional Society: The Case of SerbiaJournal of Youth Studies, 2006
- European healthcare policies for controlling drug expenditure.PharmacoEconomics, 2003